We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
19 hedge funds and large institutions have $1.84M invested in Interpace Biosciences, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
19% more capital invested
Capital invested by funds: $1.54M → $1.84M (+$296K)
6% more funds holding
Funds holding: 18 → 19 (+1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.2K |
| 2 |
Renaissance Technologies
New York
|
+$1.09K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$753 |
| 4 |
Morgan Stanley
New York
|
+$38 |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$38.9K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$903 |
| 5 |
Goldman Sachs
New York
|
-$565 |
